Compounds > carbapenems
Page last updated: 2024-09-04

carbapenems and iclaprim

carbapenems has been researched along with iclaprim in 3 studies

Compound Research Comparison

Studies
(carbapenems)		Trials
(carbapenems)		Recent Studies (post-2010)
(carbapenems)		Studies
(iclaprim)		Trials
(iclaprim)		Recent Studies (post-2010) (iclaprim)
7,3551475,27745716

Protein Interaction Comparison

ProteinTaxonomycarbapenems (IC50)iclaprim (IC50)
Dihydrofolate reductaseHomo sapiens (human)0.486
Dihydrofolate reductaseStaphylococcus aureus0.3076
Dihydrofolate reductaseEscherichia coli K-120.4858
Dihydrofolate reductasePneumocystis carinii0.9644
Dihydrofolate reductaseStreptococcus pneumoniae TIGR40.6055

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
French, GL1
Micek, ST; Neuner, EA; Ritchie, DJ1
Cattoir, V; Daurel, C1

Reviews

3 review(s) available for carbapenems and iclaprim

ArticleYear
What's new and not so new on the antimicrobial horizon?
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14 Suppl 6

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Cephalosporins; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Pyrimidines; Research

2008
New antibiotics for healthcare-associated pneumonia.
    Seminars in respiratory and critical care medicine, 2009, Volume: 30, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Cross Infection; Doripenem; Glycopeptides; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Pseudomonas Infections; Pyrimidines; Staphylococcal Infections; Teicoplanin

2009
[Update on antimicrobial chemotherapy].
    Medecine et maladies infectieuses, 2010, Volume: 40, Issue:3

    Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Daptomycin; Doripenem; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; France; Humans; Linezolid; Lipoglycopeptides; Minocycline; Oxazolidinones; Penicillins; Pyrimidines; Teicoplanin; Tigecycline

2010